984
Views
64
CrossRef citations to date
0
Altmetric
Original Articles

Patterns of Abstinence or Continued Drug Use Among Methadone Maintenance Patients and Their Relation to Treatment Retention

, M.A., , Ph.D., , , M.D., , B.A. & , M.D.

REFERENCES

  • Amato, L.; Minozzi, S.; Davoli, M. & Vecchi, S. 2011. Psychosocial and pharmacological treatments versus pharmacological treatments for opioid detoxification. Cochrane Database of Systematic Reviews 9: CD005031.
  • Backmund, M.; Meyer, K.; Henkel, C.; Soyka, M.; Reimer, J. & Schutz, C.G. 2005. Co-consumption of benzodiazepines in heroin users, methadone-substituted and codeine-substituted patients. Journal of Addictive Diseases 24 (4): 17–29.
  • Ball, J.C. & Ross, A. 1991. The Effectiveness of Methadone Maintenance Treatment. New York: Springer-Verlag.
  • Bart, G. 2012. Maintenance medication for opiate addiction: The foundation of recovery. Journal of Addictive Diseases 31 (3): 207–225.
  • Bell, J.; Burrell, T.; Indig, D. & Gilmour, S. 2006. Cycling in and out of treatment: Participation in methadone treatment in NSW, 1990–2002. Drug and Alcohol Dependence 81 (1): 55–61.
  • Best, D.; Gossop, M.; Greenwood, J.; Marsden, J.; Lehman, P. & Strang, J. 1999a. Cannabis use in relation to illicit drug use and health problems among opiate misusers in treatment. Drug and Alcohol Review 18 (1): 31–38.
  • Best, D.; Gossop, M.; Stewart, D.; Marsden, J.; Lehmann, P. & Strang, J. 1999b. Continued heroin use during methadone treatment: Relationships between frequency of use and reasons reported for heroin use. Drug and Alcohol Dependence 53 (3): 191–195.
  • Best, D.; Harris, J.; Gossop, M.; Farrell, M.; Finch, E.; Noble, A. & Strang, J. 2000. Use of non-prescribed methadone and other illicit drugs during methadone maintenance treatment. Drug and Alcohol Review 19 (1): 9–16.
  • Brands, B.; Blake, J.; Marsh, D.C.; Sproule, B.; Jeyapalan, R. & Li, S. 2008. The impact of benzodiazepine use on methadone maintenance treatment outcomes. Journal of Addictive Diseases 27 (3): 37–48.
  • Caplehorn, J.R. & Bell, J. 1991. Methadone dosage and retention of patients in maintenance treatment. Medical Journal of Australia 154 (3): 195–199.
  • Caplehorn, J.R.M.; Lumley, T. & Irwig, L. 1998. Staff attitudes and retention of patients in methadone maintenance programs. Drug and Alcohol Dependence 52 (1): 57–61.
  • Carpentier, P.J.; Krabbe, P.F.; van Gogh, M.T.; Knapen, L.J.; Buitelaar, J.K. & de Jong, C.A. 2009. Psychiatric comorbidity reduces quality of life in chronic methadone maintained patients. American Journal of Addiction 18 (6): 470–480.
  • Chatham, L.R.; Rowan-Szal, G.A.; Joe, G.W. & Simpson, D.D. 1997. Heavy drinking, alcohol-dependent vs. non-dependent methadone maintenance clients: A follow-up study. Addictive Behaviors 22 (1): 69–80.
  • Chen, K.W.; Berger, C.C.; Forde, D.P.; D’Adamo, C.; Weintraub, E. & Gahdhi, D. 2011. Benzodiazepine use and misuse among patients in a methadone program. BMC Psychiatry 11: 90.
  • Chermack, S.T.; Roll, J.; Reilly, M.; Davis, L.; Kilaru, U. & Grabowski, J. 2000. Comparison of patients self-reports and urinalysis results obtained under naturalistic methadone treatment conditions. Drug and Alcohol Dependence 59 (1): 43–49.
  • Clausen, T.; Ancherson, K. & Waal, H. 2008. Mortality prior to, during and after opioid maintenance treatment (OMT): A national prospective cross-registry study. Drug and Alcohol Dependence 94 (1–3): 151–157.
  • Coviello, D.M.; Zanis, D.A.; Wesnoski, S.A.; Lynch, K.G. & Drapkin, M. 2011. Characteristics and 9-month outcomes of discharged methadone maintenance clients. Journal of Substance Abuse Treatment 40 (2): 165–174.
  • Darke, S.; Ross, J.; Mills, K.; Teeson, M.; Williamson, A. & Havard, A. 2010. Benzodiazepine use among heroin users: Baseline use, current use and clinical outcome. Drug and Alcohol Review 29 (3): 250–255.
  • Davoli, M.; Bargagli. A.M.; Perucci C.A.; Schifano, P.; Belleudi, V.; Hickman, M.; Salamina, G.; Diecidue, R.; Vigna-Taglianti, F.; Faggiano, F. & VEdeTTE Study Group. 2007. Risk of fatal overdose during and after specialist drug treatment: The VEdeTTE study: A national multi-site prospective cohort study. Addiction 102 (12): 1954–1959.
  • Davstad, I.; Stenbacka, M.; Leifman, A.; Beck, O.; Kormaz, S. & Romelsjö, A. 2007. Patterns of illicit drug use and retention in a methadone program: A longitudinal study. Journal of Opioid Maintenance 3 (1): 27–34.
  • Deck, D. & Carlson, M.J. 2005. Retention in publicly funded methadone maintenance treatment in two Western states. Journal of Behavioral Health Services & Research 32 (1): 43–60.
  • Dobler-Mikola, A.; Hattenschwiler, J.; Melli, D.; Beck, T.; Boni, E. & Modestin, J. 2005. Patterns of heroin, cocaine, and alcohol abuse during long-term methadone maintenance treatment. Journal of Substance Abuse Treatment 29 (4): 259–265.
  • Dole, V.P. 1994. What have we learned from three decades of methadone maintenance treatment? Drug and Alcohol Review 13 (1): 3–4.
  • Dole, V.P. & Nyswander, M.E. 1967. Heroin addiction—a metabolic disease. Archives of Internal Medicine 120 (1): 19–24.
  • Dole, V.P.; Nyswander, M.E. & Kreek, M.J. 1966. Narcotic blockade. Archives of Internal Medicine 118 (4): 304–309.
  • Epstein, D.H. & Preston, K.L. 2003. Does cannabis use predict poor outcome for heroin-dependent patients on maintenance treatment? Past findings and more evidence against. Addiction 98 (3): 269–279.
  • Faggiono, F.; Vigna-Tagliantiu, F.; Versino, E. & Lemma, P. 2003. Methadone maintenance at different dosages for opioid dependence. Cochrane Database of Systematic Reviews 3: CD002208.
  • Farré, M.; Mas, A.; Torrens, M.; Moreno, V. & Cami, J. 2002. Retention rate and illicit opioid use during methadone maintenance interventions: A meta-analysis. Drug and Alcohol Dependence 65 (3): 283–290.
  • Fiellin, D.A. & O’Connor, P.G. 2002. New federal initaitves to enhance medical treatment of opioid dependence. Annals of Internal Medicine 137 (8): 688–692.
  • Gerra, G.; Saenz, E.; Busse, A.; Maremmani, L.; Ciccocioppo, R.; Zaimovic, A.; Gerra, M.L.; Amore, M.; Manfredini, M.; Donnini, C. & Somaini, L. 2011. Supervised daily consumption, take-home incentirve and non-contingent take-home in methadone maintenance. Progress in Neuro-Psychopharmacolgy & Biological Psychiatry 35 (2): 483–489.
  • Gossop, M.; Green, L.; Phillips, G. & Bradley, B. 1989. Lapse, relapse and survival among opiate addicts after treatment: A prospective follow-up study. British Journal of Psychiatry 154: 348–353.
  • Grella, C.E.; Anglin, M.D. & Wugalter, S.E. 1997. Patterns and predictors of cocaine and crack use by clients in standard and enhanced methadone maintenance. American Journal of Drug and Alcohol Abuse 23 (1): 15–42.
  • Joe, G.W.; Simpson, D.D. & Broome, K.M. 1999. Retention and patient engagement models for different treatment modalities in DATOS. Drug and Alcohol Dependence 57 (2): 113–125.
  • Joseph, H. 1995. Medical methadone maintenance: The further concealment of a stigmatized condition. Ph.D. dissertation, City University of New York, New York.
  • Joseph, H.; Stancliff, S. & Langrod, J. 2000. Methadone maintenance treatment (MMT): A review of historical and clinical issues. Mount Sinai Journal of Medicine 67 (5–6): 347–364.
  • Kellogg, S.; Melia, D.; Khuri, E.; Lin, A.; Ho, A. & Kreek, M.J. 2006. Adolescent and young adult heroin patients: Drug use and success in methadone treatment. Journal of Addictive Diseases 25 (3): 15–25.
  • Kelly, S.M.; O’Grady, K.E.; Mitchell, S.G.; Brown, B.S. & Schwartz, R.P. 2011. Predictors of methadone treatment retention from a multi-site study: A survival analysis. Drug and Alcohol Dependence 117 (2–3): 170–175.
  • Kimber, J.; Copleland, L.; Hickman, M.; Macleod, J.; McKenzie, J.; De Angelis, D. & Robertson, J.R. 2010. Survival and cessation in injecting drug users: Prospective observational study of outcomes and effect of opiate substitution treatment. BMJ 341: c3172.
  • Kleber, H. 2008. Methadone maintenance 4 decades later: Thousands of lives saved but still controversial. Journal of the American Medical Association 300 (9): 2303–2305.
  • Kreek, M.J. & Vocci, F. 2002. History and current status of opioid maintenance treatments: Blending conference session. Journal of Substance Abuse Treatment 23 (2): 93–105.
  • Lowinson, J.H.; Berle, B. & Langrod, J. 1976. Detoxification of long-term methadone patients: Problems and prospects. The International Journal of the Addictions 11 (6): 1009–1018.
  • Magura, S.; Nwakeze, P.C. & Demsky S. 1998. Pre- and in-treatment predictors of retention in methadone treatment using survival analysis. Addiction 91 (1): 51–60.
  • Magura, S. & Rosenblum, A. 2001. Leaving methadone treatment: Lessons learned, lessons forgotten, lessons ignored. Mount Sinai Journal of Medicine 68 (1): 62–74.
  • Magura, S.; Rosenblum, A.; Fong, C.K.; Villano, C. & Richman, B. 2002. Treating cocaine-using methadone patients: Predictors of outcomes in a psychosocial clinical trial. Substance Use & Misuse 37 (14): 1927–1955.
  • Mancino, M.; Curran, G.; Han, C.; Humphreys, K. & Booth, B.M. 2010. Predictors of attrition from a national sample of methadone maintenance patients. The American Journal of Drug and Alcohol Abuse 36 (3): 155–160.
  • Maremmani, I.; Pani, P.; Mellini, A.; Pacini, M.; Marini, G.; Lovrecic, M.; Perugi, G. & Shinderman, M. 2007. Alcohol and cocaine use and abuse among opioid addicts engaged in a methadone maintenance treatment program. Journal of Addictive Diseases 26 (1): 61–70.
  • Mattick, R.P.; Breen, C.; Kimber, J. & Davoli, M. 2003. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database of Systematic Reviews 2: CD002209.
  • Morral, A.R.; Belding, M.A. & Iguchi, M.Y. 1999. Identifying methadone maintenance clients at risk for poor treatment response: Pretreatment and early progress indicators. Drug and Alcohol Dependence 55 (1–2): 25–33.
  • Murphy, S. & Irwin, J. 1992. “Living with the dirty secret”: Problems of disclosure for methadone maintenance clients. Journal of Psychoactive Drugs 24 (3): 257–264.
  • National Consensus Development Panel on Effective Medical Treatment of Opiate Addiction. 1998. Effective medical treatment of opiate addiction. Journal of the American Medical Association 280 (22): 1936–1943.
  • National Institute on Drug Abuse. 1999. Principles of Addiction Medicine: A Research-based Guide, NIH Publication No. 99–1180. Rockville, MD: National Institute on Drug Abuse.
  • Noble, A.; Best, D.; Man, L.-H.; Gossop, M. & Strang, J. 2002. Self-detoxification attempts among methadone maintenance patients: What methods and what success? Addictive Behaviors 27 (4): 575–584.
  • Nosyk, B.; Sun, H.; Evans, E.; Marsh, D.C.; Anglin, M.D.; Hser, Y.-I. & Anis, A.H. 2012. Defining dosing patterns characteristics of successful tapers following methadone maintenance treatment: Results from a population-based retrospective study. Addiction 107 (9): 1621–1629.
  • Pani, P.P.; Maremmani, I.; Pacini, M.; Lamanna, F.; Maremmani, A.G. & Dell’Osso, L. 2011. Effect of psychiatric severity on the outcome of methadone maintenance treatment. European Addiction Research 17 (2): 80–89.
  • Parrino, M. 2008. Coordinating methadone treatment providers and policymakers: Lessons learned over 30 years. Heroin Addiction and Related Clinical Problems 11 (1): 43–46.
  • Pecoraro, A.; Ma, M. & Woody, G. 2012. The science and practice of medication-assisted treatment for opioid dependence. Substance Use & Misuse 47 (8–9): 1026–1040.
  • Peles, E.; Schreiber, S. & Adelson, M. 2006. Factors predicting retention in treatment: 10-year experience of a methadone maintenance treatment (MMT) clinic in Israel. Drug and Alcohol Dependence 82 (3): 211–217.
  • Petry, N.M. & Martin, B. 2002. Low-cost contingency management for treating cocaine- and opioid-abusing methadone patients. Journal of Consulting and Clinical Psychology 70 (2): 398–405.
  • Potter, J.S.; Marino, E.N.; Hillhouse, M.P.; Nielsen, S.; West, K.; Canamar, C.P.; Martin, J.A.; Ang, A.; Baker, R.; Saxon, A.J. & Ling, W. 2013. Buprenorphine/naloxone and methadone maintenance treatment outcomes for opioid analgesic, heroin and combined users: Findings from Starting Treatment with Agonist Replacement Therapies (START). Journal of Studies on Alcohol and Drugs 74 (4): 605–613.
  • Rittmansberger, H.; Silberbauer, C.; Lehner, R. & Ruschak, M. 2000. Alcohol consumption during methadone maintenance treatment. European Addiction Research 6 (1): 2–7.
  • Rowan-Szal, G.A.; Chatham, L.R. & Simpson, D.D. 2000. Importance of identifying cocaine and alcohol dependent methadone clients. The American Journal on Addictions 9 (1): 38–50.
  • Ruetsch, C.; Tkacz, J.; McPherson, T.L. & Cacciola, J. 2012. The effect of telephonic patient support on treatment for opioid dependence: Outcomes at one year follow-up. Addictive Behaviors 37 (5): 686–689.
  • Schiff, M.; Levit, S. & Moreno, R.C. 2007. Retention and illicit drug use among methadone patients in Israel: A gender comparison. Addictive Behaviors 32 (10): 2108–2119.
  • Shah, N.G.; Celentano, D.D.; Vlahov, D. & Strathdee, S.A. 2006. Longitudinal predictors of injection cessation and subsequent relapse among a cohort of injection drug users in Baltimore, MD, 1988–2000. Drug & Alcohol Dependence 83 (2): 147–156.
  • Simpson, D.D.; Joe, G.W.; Broome, K.M.; Hiller, M.L.; Knight, K. & Rowan-Szal, G.A. 1997. Program diversity and treatment retention rates in the Drug Abuse Treatment Outcome Study (DATOS). Psychology of Addictive Behaviors 11 (4): 279–293.
  • Srivastava, A.; Kahan, M. & Ross, S. 2008. The effect of methadone maintenance on alcohol consumption: A systematic review. Journal of Substance Abuse Treatment 34 (2): 215–223.
  • Stancliff, S.; Myers, J.E.; Steiner, S. & Drucker, E. 2002. Beliefs about methadone in an inner city methadone clinic. Journal of Urban Health 79 (4): 571–578.
  • Stenbacka, M.; Beck, O.; Leifman, A.; Romelsjo, A. & Helander, A. 2007. Problem drinking in relation to treatment outcome among opiate addicts in methadone maintenance treatment. Drug and Alcohol Review 26 (1): 55–63.
  • Strike, C.J.; Gnam, W.; Urbanoski, K.; Fischer, B.; Marsh, D.C. & Millson, M. 2005. Factors predicting 2-year retention in methadone maintenance for treatment of opioid dependence. Addictive Behaviors 30: 1025–1028.
  • Substance Abuse and Mental Health Services Administration, Office of Applied Studies. 2008. Treatment Episode Data Set (TEDS): 2005. Discharges from Substance Abuse Treatment Services , DASIS Series: S-41, DHHS Publication No. (SMA) 08-4314. Rockville, MD: Substance Abuse and Mental Health Services Administration, Office of Applied Studies.
  • Trenz, R.; Penniman, T.; Scherer, M.; Zur, J.; Rose, J. & Latimer, W. 2012. Problem recognition, intention to stop use, and treatment use among regular heroin injectors. Journal of Substance Abuse Treatment 43 (2): 204–210.
  • Vigilant, L.G. 2004. The stigma paradox in methadone maintenance: Naïve and positive consequences of a “treatment punishment” approach to opiate addiction. Humanity and Society 28 (4): 403–418.
  • Vigilant, L.G. 2008. “I am still suffering”: The dilemma of multiple recoveries in the lives of methadone patients. Sociological Spectrum 28 (3): 278–298.
  • Villafranca, S.W.; McKellar, J.D.; Trafton, J.A. & Humphreys, K. 2006. Predictors of retention in methadone programs: A signal detection analysis. Drug and Alcohol Dependence 83 (3): 218–224.
  • Weizman, T.; Gelkopf, M.; Melamed, Y.; Adelson, M. & Bleich, A. 2004. Cannabis abuse is not a risk factor for treatment outcome in methadone maintenance treatment: A 1-year prospective study in Israeli clinic. Australian and New Zealand Journal of Psychiatry 38 (1–2): 42–46.
  • White, W.L.; Campbell, M.D.; Spencer, R.A.; Hoffman, H.A.; Crissman, B. & DuPont, R.L. In press. Participation in Narcotics Anonymous and Alcoholics Anonymous and abstinence outcomes of 322 methadone maintenance patients. Journal of Groups in Addiction and Recovery.
  • White, W.L. & Torres, L. 2010. Recovery-oriented Methadone Maintenance. Chicago, IL: Great Lakes Addiction Technology Transfer Center, Philadelphia Department of Behavioral Health and Mental Retardation Services and Northeast Addiction Technology Transfer Center.
  • Zhang, Z.; Friedmann, P.D. & Gerstein, D.R. 2003. Does retention matter? Treatment duration and improvement in drug use. Addiction 98 (5): 673–684.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.